Article Details

FDA Makes Pfizer, Myovant Wait on Approval For Myfembree | BioSpace

Retrieved on: 2022-05-06 13:45:12

Tags for this article:

Click the tags to see associated articles and topics

FDA Makes Pfizer, Myovant Wait on Approval For Myfembree | BioSpace. View article details on hiswai:

Excerpt

The FDA has extended the review period for Myfembree, following the supplemental New Drug Application from Pfizer and Myovant.

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up